FRANCES LANDRUM: Open Payments
NPI 1922238260 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 29 payments from 13 companies in 2025. Trend: 2023 $1,443 · 2024 $1,456 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $338 |
| Novo Nordisk Inc | 4 | $97 |
| Corcept Therapeutics | 1 | $74 |
| Exact Sciences Corporation | 3 | $49 |
| SANOFI-AVENTIS U.S. LLC | 3 | $48 |
| Amgen Inc. | 3 | $43 |
| Medtronic, Inc. | 1 | $37 |
| Verona Pharma, Inc. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Abbott Laboratories | 1 | $25 |
Products named: Kerendia, Ozempic, Korlym, TZIELD, OTEZLA, INTERSTIM, Ohtuvayre, FARXIGA.
Industry payments across GA — which companies pay providers there.
